Skip to main content
padlock icon - secure page this page is secure

Knockdown of reticulon 4C by lentivirus inhibits human colorectal cancer cell growth

Buy Article:

$42.00 + tax (Refund Policy)

Colorectal cancer is the third most common type of cancer worldwide with high cell motility and metastatic potential. Reticulon 4C (RTN4-C) is the shortest isoform of the reticulon family protein RTN4, which may act to induce cell apoptosis and suppress tumor development. The aim of the present study was to determine the role of RTN4C in colorectal cancer, and potentially identify a novel target for antitumor therapy. To investigate the biological role of RTN4C in colorectal cancer, the expression levels of RTN4C were initially analyzed in six colorectal cancer cell lines by reverse transcriptionquantitative polymerase chain reaction and western blot analysis. In addition, lentivirusbased RNA interference was utilized to knock down RTN4C expression in RKO and DLD1 cells with low and high levels of RTN4C, respectively. The rate of proliferation decreased in RTN4C silenced RKO and DLD1 cells compared with the control, as determined using MTT and colony formation assays. Flow cytometric analysis revealed that RTN4C knockdown in RKO cells led to cell cycle arrest at the G0/G1 phase, particularly at the subG1 phase representing apoptotic cells. These results indicate that RTN4C has an important role in colorectal cancer cell growth, which may provide a potential therapeutic approach for human colorectal cancer.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Affiliations: 1: Neijing Institution of the Basic Medical College, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China 2: Department of General Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China

Publication date: August 1, 2015

More about this publication?
  • Molecular Medicine Reports is a monthly, peer-reviewed journal available in print and online, that includes studies devoted to molecular medicine, underscoring aspects including pharmacology, pathology, genetics, neurosciences, infectious diseases, molecular cardiology and molecular surgery. In vitro and in vivo studies of experimental model systems pertaining to the mechanisms of a variety of diseases offer researchers the necessary tools and knowledge with which to aid the diagnosis and treatment of human diseases.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more